Case Study

Engaging Key Stakeholders For A Clinical Biopharma Focused On Autism Spectrum Disorders


A clinical biopharmaceutical company focused on autism spectrum disorders (ASD) wanted to share its progress with key stakeholders, including existing and potential investors.

The company appointed us to develop engaging communications that highlighted its progress.


To develop ideas for content, we interviewed senior members of the team as well as key opinion leaders involved in the clinical study.


We produced a comprehensive suite of materials highlighting the company’s progress, achievements, as well as the team’s relationship with the research community. We focused on key messages to differentiate the company’s technology and demonstrate its potential in redefining the way ASD is diagnosed and treated.